A Study to Evaluate Subcutaneous Durvalumab in Patients With Non-Small Cell Lung Cancer and Small Cell Lung Cancer

Clinical trial NCT04870112 · TERMINATED

Trial details

NCT number: NCT04870112
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Small Cell Lung Cancer

Start date: 2021-06-28
Primary completion: 2023-08-30
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.